Tag: OTCQX:LXRP

July 11, 2019

Lexaria Bioscience Enters CBD License Agreement with Universal Hemp

Lexaria Bioscience Enters CBD License Agreement with Universal Hemp
July 10, 2019

Lexaria Bioscience Enters CBD Beverage License Agreement with Nic’s Beverages

Lexaria Bioscience Corp. (OTCQX:LXRP, CSE:LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces that it has entered a...
June 4, 2019

Lexaria Bioscience Announces new DehydraTECH Innovation, Files New Patents

Lexaria Bioscience Corp. (CSE:LXX, OTCQX:LXRP)(the "Company" or "Lexaria"), a drug delivery platform innovator, has discovered improved performance characteristics of a...
May 28, 2019

Combining Lexaria’s DehydraTECH(TM) with Nanotech Delivers Increased Quantities of CBD into Brain Tissue

Lexaria Bioscience Corp. (CSE:LXX, OTCQX:LXRP)) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces recent animal testing proves that...
May 21, 2019

Lexaria Bioscience and Nuka Enterprises’ 1906 Expand Cannabis Product Relationship

1906 fast-acting edibles products, powered by Lexaria's DehydraTECH technology, will expand across the US in 2019 and 2020
May 15, 2019

Lexaria’s DehydraTECHTM Formulation Delivers 475% More CBD to Bloodstream after 15 Minutes than Conventional Industry Formulations

Lexaria Bioscience Corp. (CSE:LXX, OTCQX:LXRP)  (the "Company" or "Lexaria"), a drug delivery platform innovator, has proven in animal testing that...
May 7, 2019

Lexaria Bioscience Announces CBD-Beverage Formulation License Agreement with Nevada-Based Company

Lexaria Bioscience Corp. (CSE:LXX, OCTQX:LXRP) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces that it has entered a...